Page 514 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 514

502        FLUID THERAPY


            nervous   system  (CNS)   secondary  to   chronic      TABLE 20-1        Adjustment in Insulin
            hyperosmolality. 25  Idiogenic osmoles are produced in                   and Dextrose
            response to plasma hyperosmolality, and they increase
            the osmolality of the brain to prevent cerebral dehydra-                 Administration Using
            tion. If the plasma osmolality decreases quickly, the                    the Continuous Low-
            idiogenic osmoles will persist and cause water accumula-                 Dose Intravenous
            tion in the cerebrum because of the difference in osmo-                  Insulin Infusion
            lality between the brain and plasma. Because of this,                    Protocol
            administration of hypotonic fluids such as 0.45% saline
            is discouraged during initial treatment. 18,43  The impor-                                Rate of
            tance of this pathophysiology in dogs and cats is unknown                              Intravenous
            and cerebral edema occurring during treatment has not  Blood Glucose   Intravenous        Insulin
            been reported, but it seems prudent to avoid rapid reduc-  Concentration   Fluid         Solution
            tion in plasma osmolality during treatment of DKA.   (mg/dL)             Solution        (mL/hr)*
            Serum tonicity, calculated from corrected serum sodium
            and glucose concentrations, did not change significantly  >250         0.9% saline          10
            during treatment of diabetic ketosis in cats despite a  200-250        0.9% saline,          7
            decrease in serum glucose concentration. 45  This is                     2.5% dextrose
                                                                 150-200           0.9% saline,          5
            because serum sodium concentration increased in most
                                                                                     2.5% dextrose
            cats, and sodium contributes considerably more to
                                                                 100-150           0.9% saline,          5
            plasma tonicity and osmolality than glucose. Attention                   5% dextrose
            to replacement of sodium deficits will offset reduction  <100          0.9% saline,      Stop insulin
            in plasma osmolality that occurs when the blood glucose                  5% dextrose       infusion
            and ketoacid concentrations decrease in initial manage-
            ment of patients with DKA. 73  Although 0.45% saline  Adapted from Macintire DK. Treatment of diabetic ketoacidosis in dogs by
            approximates the composition of electrolytes lost as a  continuous low-dose intravenous infusion of insulin. J Am Vet Med Assoc
                                                                 1993;202:1266–1272.
            result of osmotic diuresis and has been recommended
                                                                 *Intravenous insulin solution contains 2.2 U/kg (dog) or 1.1 U/kg (cat)
            for administration after rehydration, the author rarely  of regular insulin in 250 mL of 0.9% saline.
            uses it for treatment of DKA. However, if hypernatremia
            is noted during ongoing treatment and rehydration, one
            could consider administration of 0.45% NaCl.         within 2 to 4 hours of initiating fluid therapy unless
               Once the blood glucose concentration decreases to less  oliguric renal failure is present.
            than 250 mg/dL, 50% dextrose should be added to the
            0.9% saline to make a 2.5% to 5% dextrose solution. 17,52,53  Insulin Therapy
            Adjustments in the dextrose content of the fluids should  Intravenous fluid therapy will decrease the blood glucose
            be made based on Table 20-1. The addition of dextrose  concentration and reduce lactic acidosis, but insulin
            will prevent hypoglycemia and allow for continued insulin  administration is required to halt ketogenesis, increase
            administration to stop ketoacid formation.           ketone body use, decrease gluconeogenesis, promote
                                                                                                  18,43
                                                                 glucose use, and decrease proteolysis.  Ketogenesis
            Rate and Volume of Fluid Administration
                                                                 will be decreased by an insulin concentration 50% less
            The primary goal of initial fluid therapy is to restore intra-  than that required for promotion of peripheral use of glu-
            vascular fluid volume to improve tissue perfusion, includ-  cose, and consequently ketoacid formation is decreased
            ing GFR. Fluids should be administered at a rate     rapidly after insulin administration. For insulin to be most
            sufficient to replace volume deficits in 12 to 24 hours,  effective, tissue perfusion must be restored, so intrave-
            with 50% of the estimated deficit replaced in the first 4  nous fluid therapy should be instituted first. Insulin
            to 6 hours. An estimated volume of fluid to account for  sensitivity is increased by a reduction in hyperosmolality
            ongoing losses should be added to the maintenance    and decreased concentrations of counter-regulatory
            and replacement fluid volume, with special consideration  hormones that is accomplished by fluid administration.
            of urine output in the presence of polyuria. Fluids should  An additional important effect of insulin is its action on
            be administered cautiously to animals with impaired car-  electrolyte transport and resolution of acidosis that cause
            diac function or the potential for oliguric renal failure.  a transcellular shift of potassium into cells, causing hypo-
            Monitoring should consist of estimates or quantitation  kalemia. In patients with serum potassium concentrations
            of urine output, serial body weights, packed cell volume,  less than 3.5 mEq/L, insulin administration ideally
            total solids, and serum concentrations of creatinine,  should be delayed until potassium supplementation has
            electrolytes, and glucose. Urine output should be evident  successfully increased the serum potassium concentration
   509   510   511   512   513   514   515   516   517   518   519